Literature DB >> 2158305

Synthesis in vitro and application of biotinylated DNA probes for human papilloma virus type 16 by utilizing the polymerase chain reaction.

P J Day1, I S Bevan, S J Gurney, L S Young, M R Walker.   

Abstract

The polymerase chain reaction (PCR) has been used to incorporate biotinylated deoxynucleotide triphosphate analogues into a 120 bp sequence from the E6 region of human papilloma virus type 16 (HPV 16). No loss of amplification efficiency is observed utilizing concentrations of up to 200 microM-biotin-11-dUTP, or 180 microM-biotin-7-dATP and -biotin-16-dUTP (where the numbers refer to the number of carbon atoms in the spacer arms). Internally biotinylated PCR products can be detected following slot-blot or vacuum transfer to mitrocellulose or nylon filters without prior electrophoretic separation of the reactants, since unincorporated biotinylated analogues pass through the filter. Internally biotinylated PCR products can also be applied as hybridization probes in Southern blot analysis or in situ hybridization. This system enables detection of PCR products or target sequences at levels below that for 5'-biotinylated probes and can be applied in an 'open sandwich assay' without the need for a separate labelled probe currently required in conventional sandwich assays. However, as hybridization probes, sensitivity may be limited by the steric hindrance of strand hybridization possibly due to the spacer arms linking the nucleotides to the biotin molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158305      PMCID: PMC1131253          DOI: 10.1042/bj2670119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Rapid production of vector-free biotinylated probes using the polymerase chain reaction.

Authors:  Y M Lo; W Z Mehal; K A Fleming
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 4.  Analytical strategies for the use of DNA probes.

Authors:  J A Matthews; L J Kricka
Journal:  Anal Biochem       Date:  1988-02-15       Impact factor: 3.365

5.  Biotin and fluorescent labeling of RNA using T4 RNA ligase.

Authors:  R W Richardson; R I Gumport
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

6.  A method for linking fluorescent labels to polynucleotides: application to studies of ribosome-ribonucleic acid interactions.

Authors:  D E Draper; L Gold
Journal:  Biochemistry       Date:  1980-04-29       Impact factor: 3.162

7.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.

Authors:  L S Young; I S Bevan; M A Johnson; P I Blomfield; T Bromidge; N J Maitland; C B Woodman
Journal:  BMJ       Date:  1989-01-07

8.  Human papillomavirus infections in women with and without abnormal cervical cytology.

Authors:  E M de Villiers; D Wagner; A Schneider; H Wesch; H Miklaw; J Wahrendorf; U Papendick; H zur Hausen
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

9.  A comparison of non-radioisotopic hybridization assay methods using fluorescent, chemiluminescent and enzyme labeled synthetic oligodeoxyribonucleotide probes.

Authors:  M S Urdea; B D Warner; J A Running; M Stempien; J Clyne; T Horn
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  The prevalence of human papillomavirus antigen in patients with cervical intraepithelial neoplasia.

Authors:  P G Walker; A Singer; J L Dyson; K V Shah; A To; D V Coleman
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640

View more
  1 in total

1.  Human papillomavirus in breast cancer.

Authors:  A Di Lonardo; A Venuti; M L Marcante
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.